Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency

Abstract

Both cellular and humoral immunodeficiency develop in vivo after prolonged infection with HIV-1, but the mechanisms are unclear1. Initial infection with HIV-1 is transmitted by macrophage (M)-tropic/non-syncytia-inducing (NSI) viruses2,3, which hyperactivate the immune system4,5, and, in one view, cause immunodeficiency by “exhaustion”4,6 of lymphoid tissue. An alternative hypothesis is that immunodeficiency is caused by the replacement of M-tropic viruses by T cell (T)-tropic/syncytia-inducing (SI) viruses, which are known to be highly cytopathic in vitro and emerge late in infected individuals around the time of transition to AIDS (refs. 1, 7–9). To test these two possibilities, we have developed an ex vivo model of humoral immunity to recall antigens using human lymphoid tissue. This tissue suppo rts productive infection with both M- and T-tropic HIV-1 isolates when cultured ex vivo10,11. We found that specific immune responses were enhanced by productive infection of the tissue with M-tropic/NSI HIV-1 isolates, but were blocked by T-tropic/SI HIV-1 isolates. The mechanism involves specific irreversible effect on B-cell activity. Our results support the hypothesis that the phenotype switch to T-tropic viruses is a key determinant of acquired humoral immunodeficiency in patients infected with HIV.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Fauci, A.S. Host factors and the pathogenesis of HIV-induced disease. Nature 384, 529–534 (1996).

    Article  CAS  PubMed  Google Scholar 

  2. Zhu, T. et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261, 1179–1181 (1993).

    Article  CAS  PubMed  Google Scholar 

  3. Cornelissen, M. et al. Syncytium-inducing (SI) phenotype suppression at seroconver-sion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virol. 69, 1810–1818 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Muro-Cacho, C.A., Pantaleo, G. & Fauci, A.S. Analysis of apoptosis in lymph nodes of HIV-infected persons.Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154, 5555–5566 (1995).

    Google Scholar 

  5. Ott, M. et al.Immune hyperactivation of HIV-1 -infected T cells mediated by Tat and the CD28 pathway. Science 275, 1481–1485 (1997).

    Article  CAS  PubMed  Google Scholar 

  6. Pantaleo, G. & Fauci, A.S. New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 13, 487–512 (1995).

    Article  CAS  PubMed  Google Scholar 

  7. Tersmette, M. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1, 983–985 (1989).

    Article  CAS  PubMed  Google Scholar 

  8. Schuitemaker, H. et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66, 1354–1360 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Connor, R.I., Mohri, H., Cao, Y. & Ho, D.D. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67, 1772–1777 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Glushakova, S., Baibakov, B., Margolis, L.B. & Zimmerberg, J. Infection of human tonsil histocultures: A model for HIV pathogenesis. Nature Med. 1, 1320–1322 (1995).

    Article  CAS  PubMed  Google Scholar 

  11. Glushakova, S., Baibakov, B., Zimmerberg, J. & Margolis, L. Experimental HIV infection of human lymphoid tissue: Correlation of CD4+ T cell depletion and virus syn-cytium-inducing/non-syncytium-inducing phenotype in histoculture inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res. Hum. Retrovir. 13, 461–471 (1997).

    Article  CAS  PubMed  Google Scholar 

  12. Barbi, M. et al.Immunization in children with HIV seropositivity at birth: Antibody response to polio vaccine and tetanus toxoid. AIDS 6, 1465–1469 (1992).

    Article  CAS  PubMed  Google Scholar 

  13. Combadiere, C., Ahuja, S.K., Tiffany, H.L. & Murphy, P.M. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1 a, MIP-113, and RANTES. J. Leukoc. Biol. 60, 147–152 (1996).

    Article  CAS  PubMed  Google Scholar 

  14. Oberlin, E. et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833–5 (1996).

    Article  CAS  PubMed  Google Scholar 

  15. Clark, E.A. & Ledbetter, J.A. How B and T cells talk to each other. Nature 367, 425–428 (1994).

    Article  CAS  PubMed  Google Scholar 

  16. Kehry, M.R., Castle, B.E. J.J. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells: A redefinition of the TI-2 vs. T cell-dependent antigen dichotomy. J. Immunol. 154, 1177–1187 (1995).

    PubMed  Google Scholar 

  17. Mishell, R.I. & Dutton, R.W. Immunization of normal mouse spleen cell suspensions in vitro . Science 1004–1006 (1966).

    Article  CAS  PubMed  Google Scholar 

  18. Hoffman, M.K., Schmidt, D. & Oettgen, H.F. Production of antibody to sheep red blood cells by human tonsil cells in vitro . Nature 243, 408–410 (1973).

    Article  CAS  PubMed  Google Scholar 

  19. Lane H.C., Volkman, D.J., Whalen, G. & Fauci, A.S. In vitro antigen-induced, antigen-specific antibody production in man: Specific and polyclonal components, kinetics, and cellular requirements. J. Exp. Med. 154, 1043–1057 (1981).

    Article  CAS  PubMed  Google Scholar 

  20. Roos, M.T. et al. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J. Infect. Dis. 165, 427–432 (1992).

    Article  CAS  PubMed  Google Scholar 

  21. Kroon, F.P., Van Dissel, J.T., de Jong, J.C. & van Furth, R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 8, 469–76 (1994).

    Article  CAS  PubMed  Google Scholar 

  22. Lane, H.C. et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309, 453–458 (1983).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glushakova, S., Grivel, JC., Fitzgerald, W. et al. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nat Med 4, 346–349 (1998). https://doi.org/10.1038/nm0398-346

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0398-346

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing